{"slug":"semax-adderall-neuroprotection","verification":{"valid":true,"entries":23,"head":"564a2c9b89403f4f3727afc30e0bc352fec6e80f3a7690fad6a5a1c82ae546eb"},"energy":{"passes":23,"tokens_in":16293,"tokens_out":2314,"tokens_total":18607,"cost_usd":0,"models":{"grok/grok-4.3":2,"grok-4.3":6,"system/audit-repair":8,"kimi/moonshot-v1-8k":2,"gemini/gemini-2.5-flash":1,"repair":1,"fill-slots":2,"owner":1},"head":"564a2c9b89403f4f3727afc30e0bc352fec6e80f3a7690fad6a5a1c82ae546eb"},"provenance":[{"ts":"2026-06-29T09:14:08.806Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):\nBPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).\nTB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.\nARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.\nSemax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.\nSelank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).\nPT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).\nDSIP — Delta Sleep Inducing Peptide; natural deep sleep without Ambien-class hangover.\nKPV — Gut-specific anti-inflammatory; calms gut lining without systemic immune suppression.\nGHK-Cu — Tissue remodeling; builds collagen scaffolding. Production drops 60-80% with age.\nThymosin Alpha-1 — Immune modulation; supports immune function without suppressing it.\n\nWrite a data-first, evidence-graded article: Semax for Adderall Neuroprotection\n\nAudience: 16M on Adderall. The problem: chronic Adderall is neurotoxic to the dopamine system. Why Semax maps: upregulates BDNF which protects neurons and supports repair. Novelty: 10/10.\n\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate rat studies from human trials from user reports. No medical claims or treatment promises. Use repair-vs-suppression framing where relevant. register: source_ledger.","response":"{\n  \"slug\": \"semax-adderall-neuroprotection\",\n  \"title\": \"Semax and BDNF Upregulation: Preclinical and Limited Human Data\",\n  \"body\": \"## Background on BDNF and Dopamine System Considerations\\nChronic amphetamine exposure has been associated in preclinical models with alterations in dopamine neuron function and terminals.\\n\\n## Semax Mechanism: BDNF Modulation\\nSemax is a synthetic heptapeptide analog of ACTH(4-10).\\n\\n## Evidence on BDNF Upregulation\\n### Preclinical (Rat and Cell) Studies\\nIn rat hippocampus, a single intranasal or systemic dose of Semax (50 μg/kg) produced a maximal 1.4-fold increase in BDNF protein levels, accompanied by 1.6-fold increase in trkB tyrosine phosphorylation and 3-fold/2-fold increases in exon III BDNF and trkB mRNA (preclinical).\\n\\nMultiple rat studies document Semax-induced increases in BDNF mRNA in cortex, hippocampus, and basal forebrain within hours of administration (preclinical).\\n\\nCell culture experiments (murine glial/neuronal) showed up to 8-fold BDNF mRNA increase shortly after Semax exposure (preclinical).\\n\\n### Human Data\\nIn a clinical trial of 110 patients after ischemic stroke, Semax administration (6000 μg/day in two 10-day courses) increased plasma BDNF levels regardless of rehabilitation timing; elevated BDNF correlated with improved motor recovery and Barthel index scores (human).\\n\\nNo human trials examine Semax in the context of chronic stimulant exposure or dopamine system changes (no human data).\\n\\n## Overlap with Stimulant Pathways\\nRat studies indicate Semax can modulate striatal dopamine release and enhance effects of amphetamine on extracellular dopamine without altering baseline dopamine levels alone (preclinical).\\n\\nNo direct studies assess Semax for protection against any potential neurotoxic effects of chronic Adderall on dopamine systems (no human data; preclinical data absent on this specific pairing).\\n\\n## Framing: Repair vs Suppression\\nBDNF upregulation represents a neurotrophic signaling p","tokens_in":0,"tokens_out":0,"cost":0,"prev":"genesis","hash":"ebc9616874a08a2459fe9a1af5fe8bfc43e8e8628a0fb8a8cf2ca78d917657e1"},{"ts":"2026-06-29T11:07:12.008Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax-adderall-neuroprotection","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"ebc9616874a08a2459fe9a1af5fe8bfc43e8e8628a0fb8a8cf2ca78d917657e1","hash":"e69ace578dcda656dc34fcbc66eff13c812ad386a816c586746f613a11c3e57a"},{"ts":"2026-06-29T11:07:39.692Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax-adderall-neuroprotection","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"e69ace578dcda656dc34fcbc66eff13c812ad386a816c586746f613a11c3e57a","hash":"71bb1e33041519e3dbc06b146fa4940a4fa2259814f3d6b9120b183cb848513e"},{"ts":"2026-06-29T11:08:17.124Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax-adderall-neuroprotection","response":"7 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"71bb1e33041519e3dbc06b146fa4940a4fa2259814f3d6b9120b183cb848513e","hash":"c1087ceb67fc0d1dd808dd632869f3bfe3b459cf0fc98e0407a1c92a653fa558"},{"ts":"2026-06-29T11:09:20.663Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax-adderall-neuroprotection","response":"7 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"c1087ceb67fc0d1dd808dd632869f3bfe3b459cf0fc98e0407a1c92a653fa558","hash":"63e4f03279cc64c42c6cd266763e39506c85daacae982c6b7878c6fee3b7f72b"},{"ts":"2026-06-29T11:09:46.397Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax-adderall-neuroprotection","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"63e4f03279cc64c42c6cd266763e39506c85daacae982c6b7878c6fee3b7f72b","hash":"0396160f2fb39a2a5ae4453b0c94ecb559c951f48e8ee805bb63171d65aba924"},{"ts":"2026-06-29T12:48:58.493Z","model":"system/audit-repair","action":"repair","prompt":"","input":"semax-adderall-neuroprotection","response":"{\"materialized\":0,\"before\":[\"missing constitution slots: what_it_is, what_is_known, limitations, disclaimer\"],\"after\":[\"missing constitution slots: what_it_is, what_is_known, limitations, disclaimer\"]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"0396160f2fb39a2a5ae4453b0c94ecb559c951f48e8ee805bb63171d65aba924","hash":"f3c801bb10ad8fa656015ad6cc73bc606353791ab8e5cee83046e032935fb165"},{"ts":"2026-06-29T12:48:59.104Z","model":"system/audit-repair","action":"claim","prompt":"","input":"semax-adderall-neuroprotection c34","response":"Semax and BDNF Upregulation: Preclinical and Limited Human Data is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f3c801bb10ad8fa656015ad6cc73bc606353791ab8e5cee83046e032935fb165","hash":"3527c1d7ee70da441d75caa5bef76ef7c083a6e700678282f8afe6597daaed01"},{"ts":"2026-06-29T12:48:59.257Z","model":"system/audit-repair","action":"claim","prompt":"","input":"semax-adderall-neuroprotection c35","response":"Per this ledger on Semax and BDNF Upregulation: Preclinical and Limited Human Data: 14 scientific and 17 anecdotal sources are catalogued; 6 preclinical claim(s) summarize animal/cell literature in-catalogue.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"3527c1d7ee70da441d75caa5bef76ef7c083a6e700678282f8afe6597daaed01","hash":"fa68b6b361ed2cccbcc6b855ea1957cd8c28b264416e12bd0d6174c157a10e75"},{"ts":"2026-06-29T12:48:59.367Z","model":"system/audit-repair","action":"claim","prompt":"","input":"semax-adderall-neuroprotection c36","response":"Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"fa68b6b361ed2cccbcc6b855ea1957cd8c28b264416e12bd0d6174c157a10e75","hash":"2db6bf57e7992bc4cfb67fcd62f17bb5bd0b455e9b157a3058263a87442f8f5b"},{"ts":"2026-06-29T12:48:59.501Z","model":"system/audit-repair","action":"claim","prompt":"","input":"semax-adderall-neuroprotection c37","response":"Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"2db6bf57e7992bc4cfb67fcd62f17bb5bd0b455e9b157a3058263a87442f8f5b","hash":"1181cef46928b26de002f8214fe44f32e46a62b9151d136cb9d6ba7d1fd6e9e0"},{"ts":"2026-06-29T12:49:00.395Z","model":"system/audit-repair","action":"repair","prompt":"","input":"semax-adderall-neuroprotection","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"1181cef46928b26de002f8214fe44f32e46a62b9151d136cb9d6ba7d1fd6e9e0","hash":"7d886698800ee9885c2010f58ce95ec47ac36b12ee80e4797f359eac196bebb5"},{"ts":"2026-06-29T13:07:23.330Z","model":"kimi/moonshot-v1-8k","action":"collaborate","prompt":"","input":"semax-adderall-neuroprotection","response":"I am adding claims to address explicit gaps in knowledge and to name who claims what from anecdotes where this information is missing, as per the instructions.","tokens_in":2896,"tokens_out":452,"cost":0,"prev":"7d886698800ee9885c2010f58ce95ec47ac36b12ee80e4797f359eac196bebb5","hash":"0f9c12b405a68ca37b1abe0c10ae50385f51d31eb8b609272bf714a8d24e04bf"},{"ts":"2026-06-29T13:08:05.607Z","model":"kimi/moonshot-v1-8k","action":"collaborate","prompt":"","input":"semax-adderall-neuroprotection","response":"I am adding explicit gaps in knowledge regarding the interaction between Semax and Adderall in humans, as well as naming who claims what from anecdotes that are missing in the provided claims.","tokens_in":2900,"tokens_out":435,"cost":0,"prev":"0f9c12b405a68ca37b1abe0c10ae50385f51d31eb8b609272bf714a8d24e04bf","hash":"e66db88f263f5275e5860acb86513d77be3ca29854a403dbf9f52939a4d2bd2c"},{"ts":"2026-06-29T13:21:31.159Z","model":"system/audit-repair","action":"repair","prompt":"","input":"semax-adderall-neuroprotection","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"e66db88f263f5275e5860acb86513d77be3ca29854a403dbf9f52939a4d2bd2c","hash":"513df63cbe7e40a7553a72a2534df450a846b1398b9daf282cc904da6c9449d6"},{"ts":"2026-06-29T13:21:32.435Z","model":"system/audit-repair","action":"repair","prompt":"","input":"semax-adderall-neuroprotection","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"513df63cbe7e40a7553a72a2534df450a846b1398b9daf282cc904da6c9449d6","hash":"b9a567c81c6e9e2ca724847d130118ce6b670c15437ba0484ebcc29810d99842"},{"ts":"2026-06-29T14:34:53.086Z","model":"gemini/gemini-2.5-flash","action":"collaborate","prompt":"","input":"semax-adderall-neuroprotection","response":"Added three claims to the `who_claims_what` slot, drawing from anecdotal and speculative sources (`s6`, `s7`, `s10`) to broaden the ledger's representation of public discourse and perceived benefits of Semax. This adheres to the instruction to prefer `who_claims_what` and `what_is_unknown` slots, using only provided source IDs, and maintaining tier-honesty. I am not Grok; my output is strictly structured JSON, focused on fulfilling the specific requirements of the prompt without extraneous commentary or deviation.","tokens_in":3015,"tokens_out":463,"cost":0,"prev":"b9a567c81c6e9e2ca724847d130118ce6b670c15437ba0484ebcc29810d99842","hash":"69b612c041bef238c1cb7c46a7daa7e72233425c66783d4e540f76f71a5334b3"},{"ts":"2026-06-29T14:35:54.754Z","model":"grok/grok-4.3","action":"synthesize_body","prompt":"","input":"semax-adderall-neuroprotection","response":"## Regeneration vs degeneration — where this fits\n\nThe body breaks down tissue and builds it back at the same time. When breakdown outruns repair, problems persist. Most stimulant drugs act by forcing dopamine release. This can change dopamine neuron function over time. Semax is studied for repair pathways through BDNF. BDNF supports new neural connections and cell survival. This places Semax in the regeneration column for brain tissue.\n\n## What it is\n\nSemax is a peptide fragment derived from ACTH(4-10). It is modified to keep neurological activity while removing hormonal effects. It is studied for effects on BDNF expression and related pathways in brain tissue.\n\n## How it works\n\nStep 1: Semax reaches brain tissue.  \nStep 2: It increases BDNF protein levels and trkB receptor activity.  \nStep 3: Higher BDNF supports neuron survival and new connection formation.  \nStep 4: It also changes gene expression related to inflammation and neurotransmission.\n\n## Why it would work (logic chain)\n\nIf BDNF protein rises, then neuron survival signals increase. If neuron survival signals increase, then tissue repair capacity rises. If repair capacity rises, then protection from stress or injury becomes possible. The chain starts from measured BDNF change in animal tissue.\n\n## Why people take it\n\nPeople take it when they want focus or cognitive support. Some seek an option that differs from stimulant drugs. Some use it while taking stimulants and report reduced crash. Some use it after stopping stimulants.\n\n## How many people take it\n\nThe ledger contains 12 Reddit posts, 3 X posts, and 2 other anecdote sources. Total documented personal reports: 17. No population count exists.\n\n## Evidence inventory\n\nSources total: 31.  \nStudies catalogued: 14.  \nHuman claims: 2.  \nPreclinical claims: 8.  \nAnecdotal claims: 20.  \nHuman sources: 1 stroke trial.  \nAnimal sources: 2 rat studies on BDNF and gene expression.  \nAnecdote sources: 17.\n\n## What scientists say\n\nSource s1 (rat study): A single ","tokens_in":7482,"tokens_out":964,"cost":0,"prev":"69b612c041bef238c1cb7c46a7daa7e72233425c66783d4e540f76f71a5334b3","hash":"464d171af98a1eeb9d3be896466753d9b960d8de32945a225c3a271df25e18f6"},{"ts":"2026-06-29T18:26:40.984Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax-adderall-neuroprotection","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"464d171af98a1eeb9d3be896466753d9b960d8de32945a225c3a271df25e18f6","hash":"c7054b30acaa2391a25700ef0db7f9f4e0f5b11cc726f257b3c37e5bcb37929e"},{"ts":"2026-06-29T19:57:02.195Z","model":"repair","action":"repair","prompt":"","input":"semax-adderall-neuroprotection","response":"{\"materialized\":0,\"before\":[],\"after\":[],\"focus_stats\":{\"roles_assigned\":0,\"excluded_sources\":0,\"commercial_sources\":0,\"cut_claims\":0,\"core\":14,\"cycle\":0,\"adjacent\":0}}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"c7054b30acaa2391a25700ef0db7f9f4e0f5b11cc726f257b3c37e5bcb37929e","hash":"8415c5dcd72240976f830576f8f72e23f270c0b1091be8aea3ded7e656f88184"},{"ts":"2026-06-29T21:08:04.887Z","model":"fill-slots","action":"claim","prompt":"","input":"semax-adderall-neuroprotection c53","response":"Semax and BDNF Upregulation: Preclinical and Limited Human Data is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"8415c5dcd72240976f830576f8f72e23f270c0b1091be8aea3ded7e656f88184","hash":"b1bb9adef0f568c083f507ab2e405a695379deb32071e7d707c03c53cc547203"},{"ts":"2026-06-29T21:08:06.914Z","model":"fill-slots","action":"claim","prompt":"","input":"semax-adderall-neuroprotection c54","response":"Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"b1bb9adef0f568c083f507ab2e405a695379deb32071e7d707c03c53cc547203","hash":"737a23adda53d8b800816262e90c0d8ec08123db09aeaff4204b277778ab1734"},{"ts":"2026-07-17T02:41:51.005Z","model":"owner","action":"voxel_divide","prompt":"","input":"semax-adderall-neuroprotection","response":"34 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"737a23adda53d8b800816262e90c0d8ec08123db09aeaff4204b277778ab1734","hash":"564a2c9b89403f4f3727afc30e0bc352fec6e80f3a7690fad6a5a1c82ae546eb"}]}